Company Overview - Jichuan Pharmaceutical (SH 600566) announced on December 1 that it has not implemented any share buybacks as of November 30, 2025 [1] - The current market capitalization of Jichuan Pharmaceutical is 24.9 billion yuan [1] Revenue Composition - For the year 2024, the revenue composition of Jichuan Pharmaceutical is as follows: - Heat-clearing and detoxifying products account for 33.53% - Pediatric products account for 28.11% - Digestive products account for 14.41% - Other industries account for 9.94% - Respiratory products account for 8.13% [1]

Group 1 - The core point of the article is that Jichuan Pharmaceutical (SH 600566) announced its board meeting and provided a breakdown of its revenue composition for 2024, along with its current market capitalization of 23.8 billion yuan [1][1][1] Group 2 - Jichuan Pharmaceutical's revenue composition for 2024 is as follows: 33.53% from heat-clearing and detoxifying products, 28.11% from pediatric products, 14.41% from digestive products, 9.94% from other industries, and 8.13% from respiratory products [1][1][1] - As of the report, Jichuan Pharmaceutical's market capitalization stands at 23.8 billion yuan [1][1][1]

Group 1 - The core point of the article is that Jichuan Pharmaceutical (SH 600566) held its 16th meeting of the 10th board of directors on August 22, 2025, to review the proposal for the 2025 semi-annual report [1] - For the year 2024, the revenue composition of Jichuan Pharmaceutical is as follows: 33.53% from heat-clearing and detoxifying products, 28.11% from pediatric products, 14.41% from digestive products, 9.94% from other industries, and 8.13% from respiratory products [1]